The future of obesity management is becoming clearer. Here's what we're seeing:
• Rapid uptake of GLP-1s following Medicare obesity coverage expansion.
• Significant growth in oral GLP-1 therapies, bringing new patients into treatment.
• Increasing use of self-pay, telehealth, and direct-to-consumer pharmacy models.
These shifts signal that obesity care is becoming more consumer-driven, creating both opportunities and challenges for employers, health plans, and PBMs.
At ProAct, we're helping employers, consultants, and partners prepare for this evolving landscape through customized obesity management strategies, formulary optimization, clinical oversight, utilization management, cost-containment solutions, and emerging programs that balance access, affordability, and long-term member outcomes.
